
News|Slideshows|October 6, 2022
4 New Drugs Approved for Primary Care: Q3 2022
Author(s)Sydney Jennings
Advertisement
The third quarter has come and gone, which means Patient Care Online has compiled another list of drugs approved by the US Food and Drug Administration for conditions that are often seen in primary care. In the slides below, find details on a novel rapid-acting treatment for major depressive disorder that was the first of its kind to receive approval from FDA, a novel treatment for plaque psoraisis, and more.
Advertisement
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Issues Complete Response Letter for Cingulate ADHD Drug CTx-1301
2
FDA Approves Xocova as First Oral COVID-19 Postexposure Prophylaxis Option
3
Transdermal Hormone Therapy for VMS and Cardiovascular Risk Management
4
A Multidisciplinary Approach to VMS and Cardiovascular Health
5
















































































































































